ArticleJournal of clinical medicine2026
Real-World Outcomes of Combined Carbon-Ion Radiotherapy and Systemic Immunotherapy for Hepatocellular Carcinoma (Atezolizumab Plus Bevacizumab or Durvalumab Plus Tremelimumab): A Single-Center Retrospective Study.
Keita Maki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.